Shanghai pharmaceutical developer founded in 2016 working on global drug delivery systems - liposomes, nanocrystals, peptides and lipid nanoparticles - across new chemical entities, 505(b)(2) products and complex generics, with laboratories in Shanghai and Shandong and bases in the United States, Canada, India, England and Australia.
Aucun commentaire disponible.
Laissez votre note & commentaire